{"transactions":[{"id":743651,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:42:12.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020210","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020210/rdgdoc.xml","form_type":"4"}},{"id":905775,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T22:00:22.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026."}],"balance_after":75000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-26-004162","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926004162/rdgdoc.xml","form_type":"4"}},{"id":994373,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:08.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10793,"price":8.46,"value":91308.78,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by the Sylvie Gregoire Roth IRA."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001437749-25-035652","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035652/rdgdoc.xml","form_type":"4"}},{"id":994372,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-19T12:45:08.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10807,"price":8.46,"value":91427.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the John J. Alam Roth IRA."}],"balance_after":1484078,"source":{"system":"sec-edgar","filing":"0001437749-25-035652","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035652/rdgdoc.xml","form_type":"4"}},{"id":998171,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1707,"price":7.57,"value":12921.99,"ownership":{"direct":false,"nature":"Spouse's IRA"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1707,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":998170,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1693,"price":7.55,"value":12782.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range."}],"balance_after":1473271,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":998169,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-17T14:01:44.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":4447,"price":7.51,"value":33396.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."}],"balance_after":1471578,"source":{"system":"sec-edgar","filing":"0001437749-25-035309","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925035309/rdgdoc.xml","form_type":"4"}},{"id":1000762,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2025-11-13T13:52:00.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":5553,"price":7.35,"value":40814.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in open-market transactions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors."}],"balance_after":1467131,"source":{"system":"sec-edgar","filing":"0001437749-25-034638","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925034638/rdgdoc.xml","form_type":"4"}},{"id":1101919,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:05:20.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021275","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021275/rdgdoc.xml","form_type":"4"}},{"id":1268010,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:00:23.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":60000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-25-004071","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004071/rdgdoc.xml","form_type":"4"}},{"id":1479594,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:28:19.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, PharmD., the Reporting Person's spouse and a non-employee director of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Dr. Gregoire's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020414","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020414/rdgdoc.xml","form_type":"4"}},{"id":1669919,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:47:52.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":35500,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-24-002349","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002349/rdgdoc.xml","form_type":"4"}},{"id":1745988,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Common Stock","published_at":"2023-11-10T00:41:03.000Z","date":"2023-11-09","kind":"gift","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents one or more bona fide gifts of the Issuer's Common Stock by the Reporting Person (such shares, the \"Gift Shares\") to certain friends and/or family members who are not immediate family members sharing the same household.  In accordance with the terms of the lock-up agreement, dated March 30, 2023, by and between the Reporting Person and the Issuer (the \"Lock-Up Agreement\"), in connection with the transfer(s) of the Gift Shares, each transferee will be subject to an agreement pursuant to which the transferee agrees not to further transfer the Gift Shares prior to August 16, 2024, subject to certain exceptions, on terms substantially similar to those set forth in the Lock-Up Agreement. Following the transaction, the Reporting Person has neither investment control over nor a pecuniary interest in the Gift Shares."}],"balance_after":729539,"source":{"system":"sec-edgar","filing":"0001437749-23-031329","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923031329/rdgdoc.xml","form_type":"4"}},{"id":1780424,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:54:37.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option to purchase shares of common stock granted to Sylvie Gregoire, Pharm.D., the Reporting Person's spouse and the Chair of the Board of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026076","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026076/rdgdoc.xml","form_type":"4"}},{"id":1780423,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO & President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:54:37.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":35500,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001437749-23-026076","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026076/rdgdoc.xml","form_type":"4"}},{"id":536350,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-10-02T15:02:25.000Z","date":"2008-10-01","kind":"exercise","acquired":false,"shares":4253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":12761,"derivative":{"exercise_price":13.63,"expiration_date":"2008-12-09","underlying":"Common Stock","underlying_shares":4253},"source":{"system":"sec-edgar","filing":"0000875320-08-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000076/edgar.xml","form_type":"4"}},{"id":536349,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-10-02T15:02:25.000Z","date":"2008-10-01","kind":"sale","acquired":false,"shares":4253,"price":32.65,"value":138860.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $32.65 (range $32.30 to $33.08)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000076/edgar.xml","form_type":"4"}},{"id":536348,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-10-02T15:02:25.000Z","date":"2008-10-01","kind":"exercise","acquired":true,"shares":4253,"price":13.63,"value":57968.39,"ownership":{"direct":true},"balance_after":141045,"source":{"system":"sec-edgar","filing":"0000875320-08-000076","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000076/edgar.xml","form_type":"4"}},{"id":536785,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-09-11T20:24:00.000Z","date":"2008-09-10","kind":"exercise","acquired":false,"shares":6614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.19,"expiration_date":"2008-09-16","underlying":"Common Stock","underlying_shares":6614},"source":{"system":"sec-edgar","filing":"0000875320-08-000072","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000072/edgar.xml","form_type":"4"}},{"id":536784,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-09-11T20:24:00.000Z","date":"2008-09-10","kind":"sale","acquired":false,"shares":6614,"price":26.23,"value":173485.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $26.34 (range $26.02 to $26.42)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000072","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000072/edgar.xml","form_type":"4"}},{"id":536783,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-09-11T20:24:00.000Z","date":"2008-09-10","kind":"exercise","acquired":true,"shares":6614,"price":10.19,"value":67396.66,"ownership":{"direct":true},"balance_after":143406,"source":{"system":"sec-edgar","filing":"0000875320-08-000072","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000072/edgar.xml","form_type":"4"}},{"id":536985,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-09-04T20:14:19.000Z","date":"2008-09-03","kind":"exercise","acquired":false,"shares":6612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":6614,"derivative":{"exercise_price":10.19,"expiration_date":"2008-09-16","underlying":"Common Stock","underlying_shares":6612},"source":{"system":"sec-edgar","filing":"0000875320-08-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000071/edgar.xml","form_type":"4"}},{"id":536984,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-09-04T20:14:19.000Z","date":"2008-09-03","kind":"sale","acquired":false,"shares":6612,"price":25.86,"value":170986.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $25.86 (range $25.49 to $26.26)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000071/edgar.xml","form_type":"4"}},{"id":536983,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-09-04T20:14:19.000Z","date":"2008-09-03","kind":"exercise","acquired":true,"shares":6612,"price":10.19,"value":67376.28,"ownership":{"direct":true},"balance_after":143404,"source":{"system":"sec-edgar","filing":"0000875320-08-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000071/edgar.xml","form_type":"4"}},{"id":537235,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-08-28T17:19:15.000Z","date":"2008-08-27","kind":"exercise","acquired":false,"shares":6612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":13226,"derivative":{"exercise_price":10.19,"expiration_date":"2008-09-16","underlying":"Common Stock","underlying_shares":6612},"source":{"system":"sec-edgar","filing":"0000875320-08-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000069/edgar.xml","form_type":"4"}},{"id":537234,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-08-28T17:19:15.000Z","date":"2008-08-27","kind":"sale","acquired":false,"shares":6612,"price":27.02,"value":178656.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $27.02 (range $26.70 to $27.47)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000069/edgar.xml","form_type":"4"}},{"id":537233,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-08-28T17:19:15.000Z","date":"2008-08-27","kind":"exercise","acquired":true,"shares":6612,"price":10.19,"value":67376.28,"ownership":{"direct":true},"balance_after":143404,"source":{"system":"sec-edgar","filing":"0000875320-08-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000069/edgar.xml","form_type":"4"}},{"id":537435,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-08-21T17:52:38.000Z","date":"2008-08-20","kind":"exercise","acquired":false,"shares":6612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":19838,"derivative":{"exercise_price":10.19,"expiration_date":"2008-09-16","underlying":"Common Stock","underlying_shares":6612},"source":{"system":"sec-edgar","filing":"0000875320-08-000066","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000066/edgar.xml","form_type":"4"}},{"id":537434,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-08-21T17:52:38.000Z","date":"2008-08-20","kind":"sale","acquired":false,"shares":1920,"price":27.99,"value":53740.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on thsi line occurred at a weighted average price of $27.99 (range $27.91 to $28.10)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000066","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000066/edgar.xml","form_type":"4"}},{"id":537433,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-08-21T17:52:38.000Z","date":"2008-08-20","kind":"sale","acquired":false,"shares":4692,"price":27.4,"value":128560.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction for sales of common stock made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $27.40 (range $26.96 to $27.78)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Dr. Alam undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":138712,"source":{"system":"sec-edgar","filing":"0000875320-08-000066","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000066/edgar.xml","form_type":"4"}},{"id":537432,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-08-21T17:52:38.000Z","date":"2008-08-20","kind":"exercise","acquired":true,"shares":6612,"price":10.19,"value":67376.28,"ownership":{"direct":true},"balance_after":143404,"source":{"system":"sec-edgar","filing":"0000875320-08-000066","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000066/edgar.xml","form_type":"4"}},{"id":538695,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Options","published_at":"2008-07-25T14:56:26.000Z","date":"2008-07-24","kind":"grant","acquired":true,"shares":36250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008."}],"balance_after":36250,"derivative":{"exercise_price":32.16,"exercise_date":"2008-10-24","expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":36250},"source":{"system":"sec-edgar","filing":"0000875320-08-000052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000052/edgar.xml","form_type":"4"}},{"id":539850,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-06-23T15:21:12.000Z","date":"2008-06-19","kind":"exercise","acquired":false,"shares":3459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":0,"derivative":{"exercise_price":15.6,"exercise_date":"2003-04-18","expiration_date":"2013-01-17","underlying":"Common Stock","underlying_shares":3459},"source":{"system":"sec-edgar","filing":"0000875320-08-000046","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000046/edgar.xml","form_type":"4"}},{"id":539849,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-06-23T15:21:12.000Z","date":"2008-06-19","kind":"exercise","acquired":false,"shares":4822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":0,"derivative":{"exercise_price":15.87,"exercise_date":"2002-10-22","expiration_date":"2012-07-21","underlying":"Common Stock","underlying_shares":4822},"source":{"system":"sec-edgar","filing":"0000875320-08-000046","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000046/edgar.xml","form_type":"4"}},{"id":539848,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-06-23T15:21:12.000Z","date":"2008-06-19","kind":"exercise","acquired":true,"shares":3459,"price":15.6,"value":53960.4,"ownership":{"direct":true},"balance_after":136792,"source":{"system":"sec-edgar","filing":"0000875320-08-000046","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000046/edgar.xml","form_type":"4"}},{"id":539847,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-06-23T15:21:12.000Z","date":"2008-06-19","kind":"exercise","acquired":true,"shares":4822,"price":15.87,"value":76525.14,"ownership":{"direct":true},"balance_after":133333,"source":{"system":"sec-edgar","filing":"0000875320-08-000046","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000046/edgar.xml","form_type":"4"}},{"id":545649,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-21","kind":"sale","acquired":false,"shares":80,"price":27.89,"value":2231.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128511,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545648,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":80,"price":27.65,"value":2212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128591,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545647,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":81,"price":27.64,"value":2238.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128671,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545646,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":80,"price":27.54,"value":2203.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128752,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545645,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":80,"price":27.71,"value":2216.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128832,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545644,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":160,"price":27.61,"value":4417.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":128912,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545643,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":80,"price":27.59,"value":2207.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":129072,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":545642,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-05-22T13:24:34.000Z","date":"2008-05-20","kind":"sale","acquired":false,"shares":161,"price":27.47,"value":4422.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":129152,"source":{"system":"sec-edgar","filing":"0000875320-08-000029","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000029/edgar.xml","form_type":"4"}},{"id":559421,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2008-02-11T20:47:40.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":36250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval."}],"balance_after":36250,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-07","expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":36250},"source":{"system":"sec-edgar","filing":"0000875320-08-000003","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000003/edgar.xml","form_type":"4"}},{"id":559420,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Dev. Group & CMO"}}],"security":"Common Stock","published_at":"2008-02-11T20:47:40.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":9667,"price":0.01,"value":96.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":128511,"source":{"system":"sec-edgar","filing":"0000875320-08-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000003/edgar.xml","form_type":"4"}},{"id":562426,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":45,"price":25.96,"value":1168.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":118844,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562425,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":50,"price":25.82,"value":1291.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":118889,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562424,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":45,"price":25.6,"value":1152.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":118939,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562423,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":140,"price":25.59,"value":3582.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":118984,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562422,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":50,"price":25.58,"value":1279.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119124,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562421,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":50,"price":25.57,"value":1278.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119174,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562420,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":50,"price":25.52,"value":1276.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119224,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":562419,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-12-12T16:22:51.000Z","date":"2007-12-11","kind":"sale","acquired":false,"shares":50,"price":25.41,"value":1270.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119274,"source":{"system":"sec-edgar","filing":"0000875320-07-000121","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000121/edgar.xml","form_type":"4"}},{"id":563941,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-11-19T19:50:07.000Z","date":"2007-11-16","kind":"sale","acquired":false,"shares":1,"price":25.82,"value":25.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119324,"source":{"system":"sec-edgar","filing":"0000875320-07-000109","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000109/edgar.xml","form_type":"4"}},{"id":572893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":false,"shares":12404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":15946,"derivative":{"exercise_price":9.69,"exercise_date":"2004-06-17","expiration_date":"2014-03-16","underlying":"Common Stock","underlying_shares":12404},"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572892,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":3050,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572891,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":false,"shares":1966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan.  Fully Vested"}],"balance_after":0,"derivative":{"exercise_price":18.47,"exercise_date":"1997-12-26","expiration_date":"2007-12-25","underlying":"Common Stock","underlying_shares":1966},"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572890,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan.  Fully Vested"}],"balance_after":0,"derivative":{"exercise_price":13.67,"exercise_date":"1998-03-12","expiration_date":"2007-12-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572889,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"sale","acquired":false,"shares":30720,"price":35,"value":1075200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119324,"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572888,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":true,"shares":12404,"price":9.69,"value":120194.76,"ownership":{"direct":true},"balance_after":150044,"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572887,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":true,"shares":6350,"price":9.07,"value":57594.5,"ownership":{"direct":true},"balance_after":137640,"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572886,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":true,"shares":1966,"price":18.47,"value":36312.02,"ownership":{"direct":true},"balance_after":131290,"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":572885,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-08-08T14:24:37.000Z","date":"2007-08-06","kind":"exercise","acquired":true,"shares":10000,"price":13.67,"value":136700.0,"ownership":{"direct":true},"balance_after":129324,"source":{"system":"sec-edgar","filing":"0000875320-07-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000087/edgar.xml","form_type":"4"}},{"id":575526,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,  Med. Dev. Group & CMO"}}],"security":"Stock Option","published_at":"2007-07-16T18:00:23.000Z","date":"2007-07-12","kind":"grant","acquired":true,"shares":36250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/12/07."}],"balance_after":36250,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":36250},"source":{"system":"sec-edgar","filing":"0000875320-07-000075","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000075/edgar.xml","form_type":"4"}},{"id":579542,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-05-21T19:21:28.000Z","date":"2007-05-17","kind":"sale","acquired":false,"shares":794,"price":31.95,"value":25368.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":119324,"source":{"system":"sec-edgar","filing":"0000875320-07-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000051/edgar.xml","form_type":"4"}},{"id":580976,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":false,"shares":7626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan.  Fully Vested"}],"balance_after":0,"derivative":{"exercise_price":13.11,"exercise_date":"2000-03-02","expiration_date":"2009-12-01","underlying":"Common Stock","underlying_shares":7626},"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580975,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":false,"shares":3188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan.  Fully Vested"}],"balance_after":0,"derivative":{"exercise_price":13.63,"exercise_date":"1999-03-10","expiration_date":"2008-12-09","underlying":"Common Stock","underlying_shares":3188},"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580974,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":false,"shares":5550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan.  Fully Vested"}],"balance_after":0,"derivative":{"exercise_price":10.19,"exercise_date":"1998-12-17","expiration_date":"2008-09-16","underlying":"Common Stock","underlying_shares":5550},"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580973,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":true,"shares":7626,"price":13.11,"value":99976.86,"ownership":{"direct":true},"balance_after":119324,"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580972,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":true,"shares":3188,"price":13.63,"value":43452.44,"ownership":{"direct":true},"balance_after":111698,"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580971,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"exercise","acquired":true,"shares":5550,"price":10.19,"value":56554.5,"ownership":{"direct":true},"balance_after":108510,"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":580970,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-05-08T18:52:52.000Z","date":"2007-05-07","kind":"sale","acquired":false,"shares":32500,"price":30.59,"value":994175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1."}],"balance_after":102960,"source":{"system":"sec-edgar","filing":"0000875320-07-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000044/edgar.xml","form_type":"4"}},{"id":587653,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003."}],"balance_after":9400,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":587652,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully exercisable."}],"balance_after":1966,"derivative":{"exercise_price":18.47,"expiration_date":"2007-09-25","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":587651,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"sale","acquired":false,"shares":500,"price":35.46,"value":17730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":135460,"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":587650,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"sale","acquired":false,"shares":1000,"price":35.46,"value":35460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":135960,"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":587649,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"exercise","acquired":true,"shares":500,"price":9.07,"value":4535.0,"ownership":{"direct":true},"balance_after":136960,"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":587648,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-02-01T17:42:58.000Z","date":"2007-01-31","kind":"exercise","acquired":true,"shares":1000,"price":18.47,"value":18470.0,"ownership":{"direct":true},"balance_after":136460,"source":{"system":"sec-edgar","filing":"0000875320-07-000019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000019/edgar.xml","form_type":"4"}},{"id":588227,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003."}],"balance_after":9900,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588226,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":2966,"derivative":{"exercise_price":18.47,"expiration_date":"2007-09-25","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588225,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Stock Option","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"grant","acquired":true,"shares":54375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 01/24/2007."}],"balance_after":54375,"derivative":{"exercise_price":36.3,"exercise_date":"2007-04-24","expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":54375},"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588224,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"sale","acquired":false,"shares":500,"price":36.2,"value":18100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":135460,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588223,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"sale","acquired":false,"shares":1000,"price":36.2,"value":36200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":135960,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588222,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"exercise","acquired":true,"shares":500,"price":9.07,"value":4535.0,"ownership":{"direct":true},"balance_after":136960,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588221,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"exercise","acquired":true,"shares":1000,"price":18.47,"value":18470.0,"ownership":{"direct":true},"balance_after":136460,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588220,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"grant","acquired":true,"shares":20000,"price":0.01,"value":200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock grant made under 2006 Stock and Option Plan, vesting as to 5,000 shares on May 6, 2008, and as to 15,000 shares on May 6, 2010."}],"balance_after":135460,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588219,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Med. Product Dev. & CMO"}}],"security":"Common Stock","published_at":"2007-01-26T20:26:37.000Z","date":"2007-01-24","kind":"grant","acquired":true,"shares":12084,"price":0.01,"value":120.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 1/24/2011, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":115460,"source":{"system":"sec-edgar","filing":"0000875320-07-000010","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000010/edgar.xml","form_type":"4"}},{"id":588602,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003."}],"balance_after":493995,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588601,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 9/26/1997."}],"balance_after":494495,"derivative":{"exercise_price":18.47,"exercise_date":"1997-12-26","expiration_date":"2007-09-25","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588600,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"sale","acquired":false,"shares":500,"price":38.29,"value":19145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":103376,"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588599,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"sale","acquired":false,"shares":1000,"price":38.29,"value":38290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":103876,"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588598,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"exercise","acquired":true,"shares":500,"price":9.07,"value":4535.0,"ownership":{"direct":true},"balance_after":104876,"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588597,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-18T20:16:32.000Z","date":"2007-01-17","kind":"exercise","acquired":true,"shares":1000,"price":18.47,"value":18470.0,"ownership":{"direct":true},"balance_after":104376,"source":{"system":"sec-edgar","filing":"0000875320-07-000007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000007/edgar.xml","form_type":"4"}},{"id":588784,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003."}],"balance_after":495495,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}},{"id":588783,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Stock Options","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 5 years from 9/26/1997."}],"balance_after":495995,"derivative":{"exercise_price":18.47,"exercise_date":"1997-12-26","expiration_date":"2007-09-25","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}},{"id":588782,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"sale","acquired":false,"shares":500,"price":35,"value":17500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":103376,"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}},{"id":588781,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"sale","acquired":false,"shares":1000,"price":35,"value":35000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1."}],"balance_after":103876,"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}},{"id":588780,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"exercise","acquired":true,"shares":500,"price":9.07,"value":4535.0,"ownership":{"direct":true},"balance_after":104876,"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}},{"id":588779,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":17122,"kind":"person","name":"ALAM JOHN J","position":1,"cik":"0001197014","reported_name":"ALAM JOHN J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Medicines Dev., & CMO"}}],"security":"Common Stock","published_at":"2007-01-11T20:46:21.000Z","date":"2007-01-10","kind":"exercise","acquired":true,"shares":1000,"price":18.47,"value":18470.0,"ownership":{"direct":true},"balance_after":104376,"source":{"system":"sec-edgar","filing":"0000875320-07-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000005/edgar.xml","form_type":"4"}}],"next_cursor":"2007-01-11T20:46:21.000000Z,588779"}